Atlas Trials

SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)

Clinical trial NCT01402687 · COMPLETED

Trial details

NCT number
NCT01402687
Sponsor
Dana-Farber Cancer Institute
Status
COMPLETED
Study type
OBSERVATIONAL
Hodgkin's LymphomaNon-Hodgkin's LymphomaMultiple Myeloma
Start date
2010-10-01
Primary completion
2013-02-01
Enrollment
181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.